Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
Z Gerontol Geriatr ; 47(8): 666-72, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24271139

ABSTRACT

BACKGROUND: Glycated proteins (advanced glycation endproducts, AGE) in tissue are associated with degenerative diseases. This study evaluated the role of sRAGE (soluble receptor for advanced glycation endproducts), a decoy receptor of AGEs in blood, for the outcome of patients after coronary artery bypass grafting (CABG). METHODS: A total of 90 patients undergoing CABG were analysed in two centres. Perioperative blood samples were collected before surgery up to 1 week postoperatively. sRAGE was measured by ELISA. Patients were subdivided regarding age (< 64 versus > 70 years, 14 % versus 35 % female), euroSCORE (< 3 versus > 4, 14 % versus 29 % female) and sRAGE changes between sternotomy and end of the operation (< 30 % versus > 45 %, 33 % versus 33 % female) and subsequently analysed with respect of postoperative outcome parameters. RESULTS: Preoperative sRAGE values did not correlate with the outcome of the patients. sRAGE levels increase within 10 min from 1,539 ± 96 to 5,311 ± 187 pg/ml after sternotomy, then returning to baseline levels within 2 days after surgery. Comparing the analysed possible risk factors age, euroSCORE and sRAGE changes, no difference was observed regarding 30-day mortality. Age and the euroSCORE are superior with respect of tachyarrythmia, whereas sRAGE kinetics seems to be superior with respect of prolonged postoperative respiration time/stay in the intensive care unit or catecholamine support. CONCLUSION: A prolonged, increased intraoperative sRAGE level is a new outcome predictor for patients undergoing CABG surgery, mutually complementary to the euroSCORE.


Subject(s)
Coronary Artery Bypass/mortality , Coronary Artery Disease/mortality , Coronary Artery Disease/surgery , Outcome Assessment, Health Care/methods , Receptors, Immunologic/blood , Age Distribution , Aged , Biomarkers/blood , Coronary Artery Disease/blood , Female , Germany/epidemiology , Humans , Male , Metabolic Clearance Rate , Middle Aged , Monitoring, Intraoperative/statistics & numerical data , Prevalence , Prognosis , Receptor for Advanced Glycation End Products , Reproducibility of Results , Risk Factors , Sensitivity and Specificity , Sex Distribution , Survival Rate , Treatment Outcome
2.
Perfusion ; 28(5): 412-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23625867

ABSTRACT

OBJECTIVE: This randomized prospective study was initiated to clarify whether individualized heparin and protamine dosing has immediate effects on hemostatic activation and platelet function in adult cardiac surgery. METHODS: Sixty adults undergoing elective coronary artery bypass grafting (CABG) were assigned to receive individualized heparin and protamine (HMS group, n= 29) or a standard dose (ACT group, n=24). Measures of thrombin generation and Multiplate (Verum Diagnostica, Munich, Germany) platelet function tests were performed before and after cardiopulmonary bypass (CPB). RESULTS: HMS patients received higher heparin (p = 0.006) and lower protamine (p<0.001) doses. Post-CPB, HMS managed patients showed significantly lower thrombin generation (thrombin-antithrombin (TAT) p<0.02) than the ACT group. Moreover, HMS managed patients had a better preservation of platelet function (COL p = 0.013; ADP p = 0.04; TRAP p = 0.04). CONCLUSION: An individualized and stable heparin concentration and appropriate dosing of protamine can reduce thrombin generation and preserve platelet function, even in short-time CPB.


Subject(s)
Antifibrinolytic Agents/therapeutic use , Coronary Artery Bypass , Fibrinolytic Agents/therapeutic use , Heparin Antagonists/therapeutic use , Heparin/therapeutic use , Protamines/therapeutic use , Tranexamic Acid/therapeutic use , Adult , Aged , Blood Coagulation/drug effects , Blood Platelets/cytology , Blood Platelets/drug effects , Coronary Artery Bypass/methods , Female , Humans , Male , Middle Aged , Platelet Activation/drug effects , Prospective Studies
3.
Infection ; 40(4): 397-404, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22700379

ABSTRACT

PURPOSE: High-tech operations performed in cardiac surgery are associated with an increased risk of surgical site infections. In this study, we investigated if surgical site infections following cardiac surgery influence revision surgeries and patients' length of stay, and compared the results to German hospital infection surveillance data. METHODS: Over a period of 3 years, 2,621 patients of a cardiac surgery unit were enrolled following cardiac artery bypass graft surgery. Patients were examined for the incidence of surgical site infections, revision surgeries, and length of stay. The results were compared to the National Reference Center (NRC) data retrospectively. RESULTS: Of the observed population, 4.5 % suffer from surgical site infections, and in 7.7 % of the patients, revision surgery had to be performed. The length of stay was exceeded significantly for the patients with surgical site infections (average stay 14.5 vs. 42.2 days, p < 0.001). Compared to the NRC data, severe surgical site infections were not increased significantly. CONCLUSION: Surgical site infections resulted in revision surgeries with a significantly increased inpatient stay. However, this increase did not differ significantly from comparable German university hospitals.


Subject(s)
Coronary Artery Bypass/adverse effects , Length of Stay , Surgical Wound Infection/epidemiology , Adult , Aged , Coronary Artery Bypass/mortality , Female , Humans , Incidence , Male , Middle Aged , Patient Readmission , Reoperation , Surgical Wound Infection/microbiology
4.
Z Gerontol Geriatr ; 45(2): 102-8, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22350391

ABSTRACT

BACKGROUND: The metabolic syndrome is defined by the presence of obesity, insulin resistance, dyslipidemia, and hypertension. Advanced glycation end products (AGEs) are stable end products of the Maillard reaction, whereby AGE accumulation is considered not only a biomarker of aging but is also associated with several degenerative diseases. AGEs are recognized by several receptor molecules of which the receptor of AGEs (RAGE) is currently the most intensively studied receptor. Activation of RAGE causes an unfavorable proinflammatory state and deletion of RAGE in diabetic animals has been reported to protect against atherosclerosis. AGEs and a high fat diet are associated with cardiovascular diseases, whereas is still not clear whether a direct link between high fat nutrition and AGEs exists in vivo. MATERIALS AND METHODS: C57BL/6 and C57BL/6 RAGE -/- mice were fed a high fat diet to induce obesity. Weight, insulin, lipid levels, AGE modifications, and cardiac gene expression were analyzed. RESULTS: The absence of RAGE resulted in accelerated weight gain, increased plasma cholesterol, and higher insulin levels in obese mice. The hearts of normal and obese RAGE -/- mice contained lower levels of the AGE arginine-pyrimidine and 3DG-imidazolone than RAGE + / + animals. RAGE -/- mice also exhibited lower expression of the genes encoding the antioxidative enzymes MnSOD, Cu/ZnSOD, and ceruloplasmin in cardiac tissue, whereas the AGE receptors AGER-1, -2, and -3 were equally expressed in both genotypes. Obese mice of both strains expressed increased amounts of AGER-2. Only obese RAGE + / + mice exhibited a reduced mRNA accumulation of Cu/Zn SOD. CONCLUSION: These data suggest that RAGE is involved in the development of obesity and insulin resistance.


Subject(s)
Diet, High-Fat/methods , Dietary Fats/metabolism , Glycation End Products, Advanced/metabolism , Obesity/physiopathology , Reactive Oxygen Species/metabolism , Receptors, Immunologic/metabolism , Weight Gain , Animals , Mice , Mice, Knockout , Receptor for Advanced Glycation End Products
5.
Exp Gerontol ; 42(7): 668-75, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17482402

ABSTRACT

OBJECTIVE: A decline in the function of all organs can be detected during ageing. Although the trend appears to be stable, deviation within the elderly population is much greater in comparison to young controls. The aim of the study was to identify a marker of senescence which correlates to heart function. Advanced glycation endproducts (AGEs) accumulate with age and are associated with degenerative diseases. METHODS: Carboxymethyllysine (CML) concentrations in the pericardial fluid (as a measure of AGEs) were analysed with ELISA technique in 75 patients undergoing cardiac surgery and correlated with clinical parameters and outcome of these patients. RESULTS: CML content of pericardial fluid increases significantly with age. AGEs show an inverse correlation to left ventricular ejection fraction. High CML levels correlate with poor outcome of patients as shown by adverse cardiac events, prolonged ventilation time and prolonged stay within the Intensive Care Unit. Within all parameters, AGE concentration of the pericardial fluid fits better with the outcome of the patients in comparison to age alone. Interestingly, medical treatment with nitrates correlates with increased CML content. CONCLUSION: AGEs, in addition to being a marker of senescence, appear to represent a prognostic factor in cardiac surgery, which can be used as a predictor of patient outcome.


Subject(s)
Aging/physiology , Biomarkers/analysis , Coronary Artery Bypass , Glycation End Products, Advanced/analysis , Adult , Aged , Aged, 80 and over , Heart/growth & development , Heart/physiology , Humans , Lysine/analogs & derivatives , Lysine/analysis , Middle Aged , Pericardial Effusion/physiopathology , Predictive Value of Tests , Treatment Outcome
6.
Herzschrittmacherther Elektrophysiol ; 17(4): 191-6, 2006 Dec.
Article in German | MEDLINE | ID: mdl-17211749

ABSTRACT

BACKGROUND: An increasing number of older patients undergo cardiac surgery. Complications after cardiac surgery such as rhythm disorders, myocardial infarction and atypical symptoms frequently lead to ambulatory visits and hospitalisations. Telemonitoring might be one method for rapid and efficient detection and classification of symptoms. We examined in this pilot study if ECG-telemonitoring after cardiac surgery proves to be an useful, reliable and accepted procedure with respect to cost and risk reduction. METHODS & RESULTS: Two hundred eight patients (46 female, 162 male) received after surgery an individually adjusted portable 12-lead ECG-monitor. Within three months all incoming ECG-recordings were analysed. In total, 1387 calls from 165 patients (80% use) with ECG-recording (8,4 calls per patient) were collected. There were 235 calls (17%) because of symptoms, 51% of them were registered between 6 PM and 8 AM. Fourteen (6%) out of those 235 emergency calls with ECG-registration led to hospitalisation (n=5) or ambulatory visits next day. The remaining 221 ECG showed no pathological ECG-signs and the patients could be managed with telephonic advice, reassurance and telemedical follow up. Readmissions were due to angina pectoris, severe but unspecific chest pain and cardiac decompensation (n=3) as well as rhythm disturbances (n=2). Almost 75% of all emergency calls were recorded within the first 60 min after the onset of symptoms. CONCLUSION: Older patients reproducibly are able to telemetrically transmit electrocardiograms after a short training before discharged home. Although there is a low incidence of complications among our study population, telemedical ECG-monitoring rapidly helps to differentiate between the symptoms leading to increased patient safety and prevented further damage. The reduction of ambulatory visits and hospitalisations only for treatment of objectified symptoms may lead to a overall cost reduction in the health care system. The reduction of unnecessary hospitalisations and ambulatory visits might also contribute to an optimised time management.


Subject(s)
Angina Pectoris/diagnosis , Arrhythmias, Cardiac/diagnosis , Chest Pain/etiology , Coronary Artery Bypass , Electrocardiography, Ambulatory/instrumentation , Heart Diseases/surgery , Heart Failure/diagnosis , Heart Valve Prosthesis Implantation , Postoperative Complications/diagnosis , Telemetry/instrumentation , Aged , Angina Pectoris/epidemiology , Arrhythmias, Cardiac/epidemiology , Chest Pain/epidemiology , Electrocardiography, Ambulatory/statistics & numerical data , Female , Germany , Heart Diseases/epidemiology , Heart Failure/epidemiology , Humans , Male , Middle Aged , Patient Readmission/statistics & numerical data , Pilot Projects , Postoperative Complications/epidemiology , Referral and Consultation/statistics & numerical data , Reproducibility of Results , Telemetry/statistics & numerical data , Telephone/statistics & numerical data , Utilization Review/statistics & numerical data
7.
Diabetes Metab ; 41(5): 410-5, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25553578

ABSTRACT

AIM: During ageing, advanced glycation end-products (AGEs) accumulate in extracellular matrix proteins like collagen and contribute to a decline in organ function. As skin autofluorescence (sAF) can assess subcutaneous accumulation of fluorescent AGEs, this study aimed to investigate the relationship between AGE-modified cardiac tissue collagen and AGE-related sAF in coronary artery bypass graft (CABG) surgery patients. METHODS: Between January 2011 and January 2012, data from 72 consecutive male patients undergoing isolated CABG were prospectively recorded. Collagen fractions were isolated from the right atrial appendages of these patients by proteolysis and collagenase digestion. Collagen was quantified by hydroxyproline assay, and AGEs by AGE-related intrinsic fluorescence; sAF was measured using an autofluorescence reader. RESULTS: Biochemical analysis showed that the insoluble cardiac collagen fraction contained the highest amounts of accumulated AGEs; the AGE-related intrinsic fluorescence of this fraction increased with age (P=0.0001), blood glucose (P=0.002), HbA1c (P=0.01) and sAF (P=0.008). CONCLUSION: This study demonstrated for the first time a relationship between cardiac tissue glycation and AGE-related sAF. In addition, cardiac tissue glycation was associated with age, blood glucose and long-term glucose values in patients with coronary artery disease.


Subject(s)
Atrial Appendage/metabolism , Coronary Artery Disease/metabolism , Diabetic Angiopathies/metabolism , Glycation End Products, Advanced/metabolism , Skin/metabolism , Subcutaneous Tissue/metabolism , Up-Regulation , Age Factors , Aged , Aged, 80 and over , Animals , Biomarkers/metabolism , Collagen/chemistry , Collagen/metabolism , Coronary Artery Bypass , Coronary Artery Disease/blood , Coronary Artery Disease/complications , Coronary Artery Disease/surgery , Diabetes Mellitus, Type 2/complications , Diabetic Angiopathies/blood , Diabetic Angiopathies/surgery , Germany , Glycated Hemoglobin/analysis , Humans , Male , Optical Imaging , Prospective Studies , White People
8.
Exp Gerontol ; 39(3): 407-13, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15036400

ABSTRACT

The binding of advanced glycation endproducts (AGEs) to their receptors is known to cause changes in cell function during normal ageing and is implicated in the pathogenesis of cardiovascular disease. In this study, expression of the AGE-receptor 3 (AGE-R3) and the receptor for AGEs (RAGE) was compared on the mRNA and protein level in the ageing human heart. Western blot and RT-PCR analysis of the AGE receptors from the cardiac auricles in senescent and adult patients was performed and compared with young controls. Whereas the expressions of AGE-R3 as well as RAGE protein were significantly upregulated in the senescent population, only the upregulation of RAGE is associated with reduced heart function. Therefore, our results support a pathophysiological function for RAGE in the ageing human heart.


Subject(s)
Aging/physiology , Coronary Disease/metabolism , Glycation End Products, Advanced/analysis , Myocardium/chemistry , Receptors, Immunologic/analysis , Adult , Aged , Blotting, Western/methods , Cardiac Output , Child, Preschool , Coronary Disease/physiopathology , Glycation End Products, Advanced/genetics , Humans , Middle Aged , RNA, Messenger/analysis , Receptor for Advanced Glycation End Products , Receptors, Immunologic/genetics , Reverse Transcriptase Polymerase Chain Reaction
9.
J Heart Lung Transplant ; 20(9): 985-95, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11557194

ABSTRACT

BACKGROUND: Protection from reperfusion injury by ischemic pre-conditioning (IPC) before prolonged ischemia has been proven for the heart and the liver. We now assess the efficacy of IPC to protect lungs from reperfusion injury. METHODS: Eighteen foxhounds (25 to 30 kg) were anesthetized, intubated, and ventilated with a fraction of inspired oxygen of 0.3 at a volume-controlled mode to maintain arterial pCO2 of 30 to 40 mm Hg. After left thoracotomy, we performed warm ischemia for 3 hours by clamping the left hilus, and followed with 8 hours of reperfusion (control, n = 6). In the treated groups, IPC was performed either for 5 minutes followed by 15-minute reperfusion (n = 6, IPC-5), or by 2 successive cycles of 10-minute ischemia, followed by 10-minute reperfusion (n = 6, IPC-10) before prior to the 3-hours warm-ischemia period. Pulmonary compliance and gas exchange were determined separately for each lung, and we recorded pulmonary and systemic hemodynamics. We performed bronchoalveolar lavage (BAL) at the end of the experiment and determined total protein concentration as well as tumor necrosis factor alpha (TNF-alpha) mRNA expression in cell-free supernatant and in BAL cells, respectively. We also assessed the wet/dry ratio of the lung. RESULTS: In the controls, on reperfusion, we encountered a progressive deterioration of gas exchange, especially of the reperfused left lung, which we could largely avoid using the IPC-5 protocol. Similarly, pulmonary compliance steadily declined but was much better in the ICP-5 group. Parallel to the improvement of gas exchange and lung mechanics, we found less total alveolar protein content and TNF-alpha mRNA expression in BAL cells in the IPC-5 than in the controls. However, we did not find IPC-10 to be paralleled by a significant improvement of lung function. Neither IPC-5 nor IPC-10 influenced the pulmonary vascular resistance index or the fluid accumulation in the lung. CONCLUSION: The major finding of the present study was that 5 minutes of IPC improved lung function after 3 hours of warm ischemia of the lung.


Subject(s)
Ischemic Preconditioning, Myocardial , Lung/physiology , Myocardial Ischemia/therapy , Animals , Blood Pressure/physiology , Bronchoalveolar Lavage Fluid/cytology , Cytokines/physiology , Disease Models, Animal , Dogs , Heart Rate/physiology , Hemodynamics/physiology , Models, Cardiovascular , Pulmonary Alveoli/physiology , Pulmonary Gas Exchange/physiology , Respiratory Mechanics/physiology , Time Factors
10.
Ann N Y Acad Sci ; 1019: 228-31, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15247020

ABSTRACT

Advanced glycation end products (AGEs) are the result of a nonenzymatic reaction of reducing sugars with primary amino groups of proteins (Maillard reaction). They accumulate in various tissues in the course of aging. Because AGEs induce protein cross-links and oxidative stress (radicals) within cells and tissues, they have been implicated in the development of many degenerative diseases. Binding of AGEs to receptors like RAGE induces the release of profibrotic cytokines, such as TGF-beta or proinflammatory cytokines, such as TNF-alpha or IL-6. AGE inhibitors or breakers, such as aminoguanidine or ALT-711, inhibit the age-induced heart hypertrophy or stiffness of the large arteries. On the other hand, little is known about the physiological role of RAGE as the receptor of AGEs. Investigations about the expression of RAGE in lung tissue and lung tumors may give a hint for such a role.


Subject(s)
Receptors, Immunologic/genetics , Receptors, Immunologic/physiology , Animals , Glycation End Products, Advanced/metabolism , Heart/physiology , Humans , Hypertrophy , Interleukin-6/metabolism , Models, Biological , Myocardium/pathology , Oxidative Stress , Protein Binding , Proteins/chemistry , Receptor for Advanced Glycation End Products , Tumor Necrosis Factor-alpha/metabolism
11.
Ann Thorac Surg ; 66(5): 1795-7, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9875793

ABSTRACT

We report the case of a 41-year-old man who underwent heart transplantation after suffering from aortic dissection during the implantation of a biventricular assist device for heart failure after coronary artery bypass grafting. The biventricular assist device had to be operated by hand for 10 hours because of a technical defect. In the end perseverance won out and the patient is now doing well at 2.5 years of follow-up.


Subject(s)
Aortic Dissection/etiology , Aortic Dissection/surgery , Coronary Artery Bypass , Heart Failure/etiology , Heart Transplantation , Heart-Assist Devices/adverse effects , Adult , Equipment Failure , Heart Failure/therapy , Humans , Male , Postoperative Complications , Treatment Outcome
12.
Eur J Cardiothorac Surg ; 21(4): 606-10, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11932154

ABSTRACT

OBJECTIVES: This retrospective study evaluates the probability of survival in patients who had undergone resection for non-small cell lung cancer (NSCLC) and in whom residual disease at the resection margins was found. METHODS: During a period of 6 years, 596 patients with NSCLC were operated upon with curative intention. Residual disease at the resection margin was divided into microscopic (R1) and macroscopic (R2). RESULTS: Twenty-six patients (4.4%) showed R1 and 12 (2%) R2 residual disease. An extrabronchial (thoracic wall, vessels) R1 situation was found in five patients and a bronchial R1 infiltration in 21 cases. The bronchial resection margin was subject to peribronchial infiltration in most cases (16/21). A total of 17/21 (65%) patients with bronchial infiltration had N2 disease. Thirty day lethality was 3.8% in the R1 group. Fifteen patients had postoperative irradiation. The 5-year survival rate for patients with R1 resection was 14%. The differences in survival between patients with extrabronchial vs. bronchial infiltration and N0/N1 vs. N2 were significant using univariate analysis. Adjuvant radiation did not result (especially in N2 disease) in a survival benefit. Among 12 patients with macroscopic residual disease (R2), 3/12 (25%) died within the first 30 days after the operation, and none of the R2 patients survived the first year after the operation. CONCLUSIONS: Patients with an R1 situation have a survival rate of 14% comparable to curative resected patients (RO) in stage III. Adjuvant radiation had no clear effect on survival. Patients with macroscopic tumor (R2) should receive palliative treatment after the operation depending on their condition.


Subject(s)
Adenocarcinoma/surgery , Carcinoma, Adenosquamous/therapy , Carcinoma, Large Cell/therapy , Carcinoma, Non-Small-Cell Lung/surgery , Carcinoma, Squamous Cell/surgery , Lung Neoplasms/surgery , Adenocarcinoma/diagnosis , Adenocarcinoma/mortality , Bronchi/pathology , Bronchi/surgery , Carcinoma, Adenosquamous/diagnosis , Carcinoma, Adenosquamous/mortality , Carcinoma, Large Cell/diagnosis , Carcinoma, Large Cell/mortality , Carcinoma, Non-Small-Cell Lung/diagnosis , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/mortality , Frozen Sections , Germany/epidemiology , Humans , Lung Neoplasms/diagnosis , Lung Neoplasms/mortality , Lymph Nodes/pathology , Middle Aged , Neoplasm Staging , Neoplasm, Residual , Prognosis , Radiotherapy, Adjuvant , Retrospective Studies , Risk Factors , Survival Analysis , Thoracic Surgical Procedures , Time Factors , Treatment Outcome
13.
Eur J Cardiothorac Surg ; 21(4): 649-52, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11932162

ABSTRACT

OBJECTIVE: Iatrogenic tracheobronchial ruptures are seldom but severe complications after intubation or bronchoscopy. Therefore, we evaluated the reasons, the subsequent therapy and the outcome of patients with tracheal rupture, who were admitted to our hospital. METHODS: In a retrospective study we examined 19 patients (15 women, four men; 43-87 years) treated for acute tracheobronchial lesions. Eleven (58%) patients had a tracheobronchial rupture by single-lumen tube, four (21%) by double-lumen tube and two patients (10%) by tracheal cannula. A total of 47% of whom were carried out under emergency conditions. Two patients had a rupture due to a stiff bronchoscopy. Mean symptoms were mediastinal and subcutaneous emphysema. Two emergency collar incisions had been done. RESULTS: The localization of ruptures was in all cases in the paries membranaceus, length: 1-7 cm (mean: 4.8 cm). The interval between the onset of symptoms and the diagnose differed widely (up to 72 h), nine (47%) diagnoses were made during intubation/bronchoscopy. One patient, with a small tear (1 cm) was treated conservatively with fibrin-glue. The other 18 patients had surgical repair through a thoracotomy. The postoperative mortality was determined with 42%, which was not dependent on the rupture but basically by the underlying diseases requiring intubation. CONCLUSIONS: Iatrogenic tracheal rupture is a dangerous complication with potentially high postoperative mortality, mostly influenced by the underlying disease. Early surgical repair must be the preferred treatment.


Subject(s)
Bronchi/injuries , Iatrogenic Disease , Rupture/etiology , Trachea/injuries , Adult , Aged , Aged, 80 and over , Bronchi/surgery , Bronchoscopy/adverse effects , Female , Follow-Up Studies , Germany/epidemiology , Humans , Iatrogenic Disease/epidemiology , Intubation, Intratracheal/adverse effects , Male , Middle Aged , Radiography , Reoperation , Retrospective Studies , Risk Factors , Rupture/surgery , Thoracotomy , Trachea/diagnostic imaging , Trachea/surgery , Tracheostomy/adverse effects , Treatment Outcome
14.
Eur J Med Res ; 7(12): 544-9, 2002 Dec 17.
Article in English | MEDLINE | ID: mdl-12527500

ABSTRACT

OBJECTIVE: Evaluating the effects of prophylactic administration of IgM-enriched immunoglobulins (IVIG) on immunological- and clinical parameters in cardiac surgical patients. PATIENTS AND METHODS: 41 patients were randomized to receive either an IgM-enriched immunoglobulin (Pentaglobin(R)) preparation (1,300 ml immunoglobulin, equivalent to 65 g protein) combined with routine antibiotic prophylaxis (Group A; n = 20, 1 drop-out), or routine antibiotic prophylaxis plus placebo (Group B; n = 20). Patients were comparable with respect to their APACHE II score, comorbidity, coronary risk, operating time, clamp, and ischemic time. Endotoxin and endotoxin neutralizing capacity (ENC) were determined by a kinetic turbidimetric Limulus amebocyte lysate (LAL) assay with internal standardization. Serum levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF)-alpha, soluble TNF-Receptor I (sTNF-R1), and interleukin-10 (IL-10) were determined by ELISA. Data analysis was performed by area under the curve (AUC) calculation and ANOVA for endotoxin neutralizing capacity and by ANOVA for all other cases. RESULTS: All patients survived. Endotoxin plasma levels were generally but not significantly higher in group A than in controls, while the difference in endotoxin neutralizing capacity (ENC) reached significance. IL-6, TNF-alpha, IL-10 and TNF-R1 were not different between both groups, however. There were significantly less patients with signs of inflammation (fever, leukocytosis, hypotension) in group A (group A n = 2; group B n = 9; p<0.05). This was paralleled by a slightly reduced hospitalization period in group A patients compared to group B patients (A:12.05 +/- 3.66 vs. B:13.45 +/- 3.72 days; n.s.). All data are given as mean +/- standard deviation (SD). CONCLUSION: The results of this study support that IgM-enriched IVIG preparation are effective when used prophylactically in patients undergoing procedures with cardiopulmonary bypass. The mechanisms of endotoxin neutralization and the effect of the host immune status on the efficacy of IVIG treatment remain to be elucidated.


Subject(s)
Coronary Artery Bypass , Immunoglobulin M/administration & dosage , Sepsis/prevention & control , Adult , Aged , Cytokines/blood , Double-Blind Method , Endotoxins/toxicity , Female , Humans , Immunotherapy , Male , Middle Aged , Prospective Studies
15.
Eur J Med Res ; 8(2): 71-6, 2003 Feb 21.
Article in English | MEDLINE | ID: mdl-12626284

ABSTRACT

OBJECTIVE: Cardiopulmonary bypass is often associated with pathophysiological changes in form of systemic inflammatory response syndrome (SIRS) or multiple organ dysfunction syndrome (MODS). In the present study, we investigated plasma levels of pro- and anti-inflammatory cytokines in survivors and non-survivors from MODS in the early postoperative course following open heart surgery. DESIGN: Prospective clinical study. SETTING: A University Cardiothoracic Intensive Care Unit. METHODS: Levels of cytokines (IL-6, IL-8, IL-10, IL-18, and TGF- ) and procalcitonin (PCT) were measured at the first four postoperative days in 16 adult male patients with an Apache II-score >24 and two or more organ dysfunctions after myocardial revascularization. MAIN RESULTS: All pro-inflammatory cytokines, except for IL-6, were significantly elevated in non-survivors from MODS, with peak values at the first two postoperative days. The plasma levels of immunoinhibitory cytokines showed no differences between the groups. CONCLUSIONS: The results of our study show a different expression of pro-inflammatory cytokines in survivors and non-survivors from MODS following operations with extracorporeal circulation. In addition to Apache-II score, especially IL-8, IL-18, and PCT may be used as parameters for the prognosis of patients with organ dysfunctions after cardiac surgery.


Subject(s)
Cardiopulmonary Bypass/adverse effects , Cytokines/blood , Multiple Organ Failure/blood , Myocardial Revascularization/adverse effects , Postoperative Complications/blood , APACHE , Aged , Calcitonin/blood , Calcitonin Gene-Related Peptide , Hospitals, University , Humans , Male , Multiple Organ Failure/complications , Multiple Organ Failure/mortality , Myocardial Revascularization/mortality , Postoperative Complications/mortality , Prospective Studies , Protein Precursors/blood , Survival Rate , Systemic Inflammatory Response Syndrome/blood , Systemic Inflammatory Response Syndrome/etiology , Systemic Inflammatory Response Syndrome/mortality
16.
J Cardiovasc Surg (Torino) ; 40(1): 71-6, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10221390

ABSTRACT

BACKGROUND: In the present study the influence of different storage solutions on endothelial integrity or damage was investigated with direct methods particularly with transmission electron microscopy (TEM), scanning electron microscopy (SEM) and immunohistochemistry. METHODS: Saphenous vein segments of 10 cm in length were taken surgically from 6 male CABG-patients (aged 60-70) under standardized conditions. Each vein segment was cut into rings, which were incubated at room temperature for 45 minutes in different storage solutions, particularly in 0.9% sodium chloride solution and in buffered solution (M 199) with 5% human serum albumin respectively. Then, the vein segments were fixed in 3.5% glutaraldehyde and prepared for scanning and transmission electron microscopy to evaluate the endothelial damage. In addition, immunohistochemical staining (CD34, PECAM and Factor VIII) was performed. RESULTS: When using 0.9% sodium chloride solution, the SEM-examination revealed that 55% of the cell population was destroyed. In comparison to these findings only 26% of the endothelial cell population was damaged when the venous segment was stored in buffered solution with 5% albumin (p<0.01). In immunohistochemistry (CD34, PECAM, Factor VIII) these findings were supported. CONCLUSIONS: This study demonstrates the importance of storage solutions in regard to endothelial integrity. For best preservation of endothelium it is necessary to modify conventional storage methods. So, storage in buffered solution with albumin has shown much better endothelial cell preservation compared with physiological saline which might reduce the obliteration rate of CABG in future.


Subject(s)
Coronary Artery Bypass , Endothelium, Vascular/ultrastructure , Organ Preservation Solutions , Saphenous Vein/transplantation , Tissue Preservation , Aged , Albumins , Buffers , Humans , Immunohistochemistry , Male , Middle Aged , Saphenous Vein/pathology , Saphenous Vein/ultrastructure , Sodium Chloride
17.
Chirurg ; 71(12): 1480-3, 2000 Dec.
Article in German | MEDLINE | ID: mdl-11195067

ABSTRACT

The employment of the heart-lung machine to assisting the circulatory system for the resection of extracardial tumors is increasing because of their location, growth and infiltration. We report on three patients in whom the resection of the tumor was only possible with extracorporeal circulation (ECC). In the first patient sarcoma of the pulmonary artery and valve was resected under ECC. Artery and valve were replaced with a cryo-preserved valved bifurcation homograft. In the other patients ECC was used on the basis of tumorinfiltration of the inferior vena cava and tumor embolus of the pulmonary artery in a case of primary renal cell carcinoma, and tumor infiltration of the superior vena cava and right atrium in a case of follicular thyroid carcinoma. All patients had a good postoperative course and excellent long term survival.


Subject(s)
Heart-Lung Machine , Thoracic Neoplasms/surgery , Vascular Neoplasms/surgery , Adenocarcinoma, Follicular/diagnosis , Adenocarcinoma, Follicular/secondary , Adenocarcinoma, Follicular/surgery , Adult , Carcinoma, Renal Cell/diagnosis , Carcinoma, Renal Cell/secondary , Carcinoma, Renal Cell/surgery , Female , Heart Neoplasms/diagnosis , Heart Neoplasms/secondary , Heart Neoplasms/surgery , Humans , Kidney Neoplasms/diagnosis , Kidney Neoplasms/surgery , Male , Middle Aged , Neoplastic Cells, Circulating , Pulmonary Artery/pathology , Pulmonary Artery/surgery , Pulmonary Valve/pathology , Pulmonary Valve/surgery , Thoracic Neoplasms/diagnosis , Thoracic Neoplasms/secondary , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/surgery , Vascular Neoplasms/diagnosis , Vascular Neoplasms/secondary , Vena Cava, Inferior/pathology , Vena Cava, Inferior/surgery , Vena Cava, Superior/pathology , Vena Cava, Superior/surgery
18.
Food Funct ; 4(7): 1023-31, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23426622

ABSTRACT

Advanced glycation end products (AGEs) are the results of a chemical reaction of reactive aldehydes, such as sugars, with amino acid side chains. AGEs can be formed by the heating process of the food and taken up with the diet. They are thought to be at least in part responsible for major complications in age-related diseases. The activation of the transcription factor NF-κB plays a prominent role in AGE-induced cell signaling. This study aimed to elucidate the effect of exogenous AGEs on NF-κB activation in different cell models. Therefore a bread crust extract commonly found in a Western diet was chosen as an AGE-rich sample. Using RP-HPLC, 23 fractions from the bread crust extract were obtained. The immunodetection with specific antibodies for N-carboxymethyllysine arg-pyrimidine, pentosidine and 3-deoxyglucosone-imidazolone showed that the majority of the AGEs were located in the late fractions. Three different NF-κB reporter cell lines including NF-κB/293/GFP-Luc™, NF-κB/Jurkat/GFP™ and RAW/NF-κB/SEAPorter™ were stimulated with the 23 fractions. There was no direct correlation between the AGE content in the fractions and the cell activation. Whereas in Jurkat-T-cells, the stimulation seems to correlate at least in part with the AGE content, in HEK-293 epithelial cell nearly all fractions can stimulate NF-κB. In macrophages few fractions stimulate NF-κB whereas some fractions even inhibit the p38 MAP kinase. The highest expression of the AGE receptors like RAGE, AGER-1, AGER-2 and AGER-3 was detected in the macrophage RAW cell line. In conclusion the present study showed a new approach to study bioactive compounds in bread crust extract. The identification of the bioactive compounds is still ongoing.


Subject(s)
Epithelial Cells/metabolism , Glycation End Products, Advanced/metabolism , Macrophages/metabolism , NF-kappa B/genetics , Secale/chemistry , T-Lymphocytes/metabolism , Transcriptional Activation , Triticum/chemistry , Animals , Bread/analysis , Cell Line , Cooking , Genes, Reporter , Glycation End Products, Advanced/chemistry , Glycation End Products, Advanced/isolation & purification , HEK293 Cells , Hot Temperature , Humans , Mice , NF-kappa B/metabolism , Receptor for Advanced Glycation End Products , Receptors, Immunologic/genetics , Receptors, Immunologic/metabolism , Secale/metabolism , Species Specificity , Triticum/metabolism
19.
Med Klin Intensivmed Notfmed ; 106(2): 125-31, 2011 Oct.
Article in German | MEDLINE | ID: mdl-22038637

ABSTRACT

BACKGROUND: We examined the impact of prophylactic IABP insertion in EuroSCORE-stratified high-risk cardiac surgery patients with a score ≥8. MATERIAL AND METHODS: A randomized trial with 104 patients either without prophylactic IABP insertion (group A, n=52) or with IABP (group B, n=52) was conducted. The primary endpoint was 30-day mortality. RESULTS: The median age of the patients was 74 years and 43% of participants were females. The 30-day mortality did not differ between group A (17.3%) and group B (13.4%; p=0.78). The median hospital stay was 14 days in both groups. Intra- and postoperative IABP support was required by 13 patients (21%) in group A. The median ventilation time (14 hours versus 13 hours), median catecholamine dose, frequency of dialysis-dependent acute renal failure (28% versus 18%), cardiac indices, and frequency of a low cardiac output syndrome (26% versus 25%) did not significantly differ between groups. CONCLUSION: Prophylactic preoperative IABP insertion in EuroSCORE-stratified high-risk patients is not associated with decreased 30-day mortality.


Subject(s)
Coronary Artery Bypass/adverse effects , Heart Valve Prosthesis Implantation/adverse effects , Intra-Aortic Balloon Pumping , Postoperative Complications/prevention & control , Aged , Cardiac Output, Low/mortality , Cardiac Output, Low/prevention & control , Female , Follow-Up Studies , Hospitals, University , Humans , Male , Postoperative Complications/mortality , Risk Factors , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL